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Abstract We here describe the application of oxime bond formation
between a peptide scaffold and different aldehydes to modify the trans-
porting capabilities of penetrating peptides. We show that bonds such
as oximes offer a great synthetic advantage for the modification of the
properties of model penetrating peptides. We believe that this ap-
proach will allow the development of improved intracellular delivery ve-
hicles.
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Penetrating peptides are short amino acid sequences
with membrane transport capabilities.1–7 Although not ful-
ly necessary for membrane activity, the cationic and the
amphiphilic character are common features of a great num-
ber of penetrating peptides.1,6,8,9 The mechanism of inter-
nalization of penetrating peptides still represents a source
of major controversy.10 Initial passive diffusion assumptions
have been ruled out because of artifacts related with the cy-
toplasm distribution after cell fixation.11 Currently, it is
widely accepted that penetrating peptides can be trans-
ported by several mechanisms operating at the same time.
Additionally, the final internalization pathway of a given
peptide is often promiscuous and depends on different pa-
rameters such as concentration, nature of the cargo and size
of the corresponding supramolecular aggregates.10,12 Fur-
thermore, the highly dynamic processes involved in mem-
brane transport such as counterion exchange13,14 and mem-
brane partitioning, strongly hinder the acquisition of robust
data and the development of predictive models.6,15 Addi-
tionally, the conformational changes of the transported
peptides are difficult to discern and to study in real
time.16,17 However, it has been recently shown that the cat-
ionic arginine topology dramatically influences important
steps of the delivery process including endosomal escape.18
The formation of dynamic bonds constitutes a powerful
strategy for the preparation of amphiphilic membrane
transporters.14,19–23 Dynamic bonds such as hydrazones, ox-
imes and disulfides offer two fundamental advantages for
the synthesis of membrane carriers.24–28 First, there is a
synthetic advantage, because certain dynamic bonds (i.e.
hydrazone, oxime, disulfide) can be considered as ‘clickable
chemistry’ as they lead to the final products in short times,
with high yields and without side products. On the other
hand, dynamic bonds are sensitive to external stimuli and
therefore they can readapt to changes in the environment
along the internalization pathway.
We have recently started a research program aimed to
decipher the critical structure-activity relationships of pen-
etrating peptides. This approach is based in the implemen-
tation of dynamic chemical bonds to change (modulate) the
structures and thus the activity of initial model peptide se-
quences. In this paper we report proof of concept transport
experiments, in vesicles and in cells, of an amphiphilic
pseudo-helical short peptide that is functionalized by ox-
ime bond formation with hydrophilic and hydrophobic
electrophilic counterparts.
This parent peptide named AcP(Ox)2 (Figure 1A), where
Ac stands for acetyl N-terminal, P for peptide backbone and
Ox for the two alkoxyamine pendants, was synthesized by
solid-phase peptide synthesis using orthogonal protecting
groups (Figure S1).21 Lysine amino acids with the lateral
protecting group methyltrytil (Mtt) were employed in or-Georg Thieme Verlag  Stuttgart · New York — Synlett 2017, 28, A–E
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coupling of the Boc-protected alkoxyamine pendants (Fig-
ure S1). The peptide was terminated by acetylation, fully
deprotected, purified by reverse-phase HPLC and character-
ized by different spectroscopic techniques (see Supporting
Information). The sequence of AcP(Ox)2 was chosen to give
rise to an helical peptide with a similar number of cationic
and hydrophobic functionalities after oxime bond forma-
tion with a guanidinium aldehyde (Figure 1B). In this pep-
tide, the alkoxyamine nucleophilic moieties are located at
the interphase between the hydrophilic and the hydropho-
bic domains in order to minimize the impact over the sec-
ondary structure. The circular dichroism analysis, in water
and in trifluoroethanol (TFE), showed bands at 208 and 222
nm, respectively, indicating a certain helical behavior of this
parent peptide AcP(Ox)2. Although helical character de-
creased in aqueous conditions, it was retained at high tem-
peratures (Figure 1B).
AcP(Ox)2 is ready to react with aldehydes (H2O/DMSO/AcOH
1:1:0.05, 60 °C, 1 h) to afford the corresponding oxime-
modulated peptides that can be readily used in transport
experiments under physiological conditions and without
any further purification (Figure 1C, see Supporting Infor-
mation for details).
We carried out initial transport experiments in model
membranes to screen the transport ability of this peptide
with a short double stranded nucleotide cargo (herring
DNA, <50 base pairs). For this purpose we prepared egg
yolk phosphatidylcholine (EYPC) large unilamellar vesicles
(LUVs) loaded with the anionic fluorophore 8-hydroxy-
1,3,6-pyrenetrisulfonate (HPTS) and the cationic quencher
p-xylene-bispyridinium bromide (DPX) (Figure 2).23,24 In
this assay, the intravesicular concentrations of dye (HPTS)
and quencher (DPX) are balanced to afford minimal emis-
sion of the resting state vesicles (see Supporting Informa-
Javier Montenegro received his PhD (2009) from the University of 
Santiago de Compostela (USC, Prof. Susana López). In 2005 he was a 
visiting scientist in the group of Prof. Steven Ley (Cambridge University) 
and in 2007 he was a visiting scientist with Prof. Reza M. Ghadiri (Scripps). 
In 2009 he moved to the University of Geneva for three years of post-
doctoral studies with Prof. Stefan Matile. In 2012 he obtained a Juan de 
la Cierva fellowship (Prof. Juan R. Granja) and in 2014 a Ramon y Cajal 
contract at the Organic Chemistry Department and the CIQUS at the 
USC. In 2015 he was awarded with a Starting Grant from the European 
Research Council (ERC). His research interests lay at the interphase be-
tween organic synthetic and supramolecular chemistry applied to bio-
logical systems and the discovery of new materials. His current projects 
are focused in the topological control of supramolecular assemblies for 
broad applications such as differential sensing, controlled delivery and 
tubular-templated composites.
Figure 1  (A) Structure of the peptide R1P(Ox)2. Arginine residues are in blue, leucines and alanines in orange and reactive alkoxyamines in red. Differ-
ent electrophilic aldehyde tails employed: TIso (isovaleraldehyde), TAcet (acetone), TGly (glyceraldehyde), TGua (guanidinium aldehyde). (B) Top-view helical 
diagram (heptad) and circular dichroism spectra at different temperatures (10–60 °C) of the parent peptide AcP(Ox)2. (C) Acronym definition and 
scheme for peptide functionalization with the different aldehydes to afford oxime-modulated peptides for membrane transport applications. Color code: 
black: peptide backbone; blue: arginine; orange: leucine; red: reactive alkylhydroxylamine; purple: isovaleraldehyde; green: glyceraldehyde; brown: acetone.Georg Thieme Verlag  Stuttgart · New York — Synlett 2017, 28, A–E
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sion of the HPTS of vesicles suspensions upon sequential
addition of the different components (peptide, DNA and de-
tergent; Figure 2). The first addition of the peptide alone (at
t = 25 s) should not lead to any increase in the fluorescence
unless the cationic peptide behaves as a mere detergent.
However, if the following second addition of the anionic
DNA (at t = 50 s) leads to an increase in the fluorescence
emission, the peptide behaves as an activator of the DNA
membrane translocation (Figure 2). At the end of the exper-
iment (t = 225 s) we added a potent detergent (Triton-X-
100) to release all the vesicle contents and normalize the
data.
Figure 2  Vesicle transport experiments. (A) Scheme of the vesicle 
transport experiments. (B) Representative normalized kinetics of trans-
porter-mediated increase in HPTS fluorescence, following addition of 
peptide (5 nM, t = 25 s), DNA (herring DNA, <50 bp, 700 nM, t = 50 s) 
and Triton-X-100 (7.5 μM, t = 225 s). Kinetic traces demonstrating in-
creasing transporter activity for AcP(TGua)2 (filled blue circles), lack of ac-
tivity for the AcP(TIso)2 (filled purple squares), control experiment with 
parent peptide AcP(Ox)2 (empty black circles) and control experiment 
with only vesicles (empty gray squares).
Two different aldehydes (hydrophilic and hydrophobic)
were selected to test oxime-modulated transport in vesi-
cles, namely TGua (guanidinium aldehyde) and TIso (isovaler-
aldehyde; Figures S3 and S4). The normalized transport ki-
netics showed that the parent peptide AcP(Ox)2 was totally
inactive (Figure 2B). However, an important increase in the
activity was observed after the oxime linkage of the peptide
with the cationic hydrophilic aldehyde TGua (Figure 2B). In-
creasing the hydrophobic character of the parent peptide
with the leucine mimic TIso did not increase the transport
activity. This result is in clear contrast with previous obser-
vations of dendritic hydrazone and oxime-based amphi-
philes,24,29–31 which required a strong hydrophobic enrich-
ment in order to activate DNA transport across the lipid bi-
layer of LUVs.
To further investigate and visualize oxime-modulated
peptides in cells, the peptide was terminated with a car-
boxyfluorescein (CF) fluorescent probe (Figure 1A, Figure
S5). After fluorophore attachment, the labelled parent pep-
tide was not completely stable so it was directly reacted
with three different electrophile modulators, namely glyc-
eraldehyde (TGly, neutral hydrophilic, Figure S6), guanidini-
um aldehyde (TGua, cationic hydrophilic, Figure S7) and ace-
tone (TAcet, hydrophobic, Figure S8).
After reaction with the aldehydes the three stable ox-
ime-bonded peptides were incubated with HeLa cells and
the uptake was quantified after cell washings and tryp-
sinization to remove the excess of the membrane-bound
peptides (Figure 3A, see Supporting Information). Interest-
ingly, the three peptides [CFP(TGly)2, CFP(TAcet)2, CFP(TGua)2]
showed higher levels of internalization than the prototypi-
cal octaarginine penetrating peptide CFR8 (Figure 3A). In-
triguingly, the incorporation of the cationic TGua lead to the
highest level of internal fluorescence, which was in good
agreement with the DNA transport experiments in vesicles.
Cell viability in the presence of the three oxime peptides
was studied by following the colorimetric 2,5-diphen-
yltetrazolium bromide reduction to formazan (MTT assay,
see Supporting Information). Interestingly, this assay con-
firmed that cationic enhancement did not only improve the
uptake but also the cellular viability (Figure 3B). The pep-
tide modified by oxime bond formation with acetone in-
duced a reduction of cell viability probably due to mem-
brane disruption of the more hydrophobic peptide (Figure 3B).
The three peptides were also studied using inverted epi-
fluorescence microscopy after incubation at 4 μM with
HeLa cells (Figure 3C). The pictures confirmed a different
behavior of the three peptides in cells (Figure 3C). The octa-
arginine control peptide (CFR8) showed the typical combi-
nation of cytoplasm distribution together with tiny punc-
tate fluorescence, indicating membrane translocation and
energy-dependent endocytosis (Figure 3C).10 The peptide
modified with the neutral glyceraldehyde, CFP(TGly)2,
showed a higher level of bigger internal aggregates suggest-
ing an increase in the size of the transported particles. The
peptide capped with acetone, CFP(TAcet)2, showed a diffuse
cytoplasmic distribution. A similar behavior, but to a great-
er extent, was observed for the amphiphilic peptide modi-
fied with the cationic aldehyde [CFP(TGua)2]. The clear en-
hancement of transport efficiency in vesicles and in cells
confirmed that the guanidinium derivative R1P(TGua)2 was
the leader of this small series.
To get further insight into the internalization mecha-
nism and confirm the endosomal pathway, we performed
microscopy experiments in HeLa cells in the presence of
LysoTracker Deep Red (Figure 4). These experiments con-
firmed that the punctate fluorescence was due to the pres-
ence of endosomes for the octa-arginine (CFR8) and the
glyceraldehyde oxime peptide [CFP(TGly)2; Figure 4]. The mem-
brane transport properties of penetrating peptides are
highly dependent on the concentration of the cellular incu-
bation experiment.1,4 Therefore, to avoid signal saturation
and to check for the potential endocytosis of the highly ac-Georg Thieme Verlag  Stuttgart · New York — Synlett 2017, 28, A–E
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hydes we carried out a one half dilution of the initial con-
centrations. We observed that [CFP(TGua)2] showed a very
similar pattern as the CFR8 and the fluorescence image, in
the presence of LysoTracker, showed cytoplasm distribution
together with co-localization in the lysosomes (Figure 4).
The peptide capped with acetone did not show the similar
co-localization, an observation that could be related to the
membrane lytic properties and a potential endosomal dis-
ruption of the more hydrophobic CFP(TAcet)2.
Increasing cationic and hydrophobic character of pene-
trating peptides can lead to toxic undesired effects.1 How-
ever, in the particular example reported here, increasing the
cationic character by introducing more guanidinium alde-
hydes in a parent amphiphilic peptide strongly increased
the cellular uptake (Figure 3B). This increase in uptake ob-
served for the peptide [CFP(TGua)2] could suggest the impor-
tance of the hydrophobicity of the leucine moieties that
would enhance the membrane partition and the penetrat-
ing properties of any given peptide.
These results confirmed the important consequences in
the transport activity after covalent/dynamic modification
of an initial parent penetrating peptide scaffold. Although
much more data will be required to validate this trend, the
results reported here suggest that the hydrophilicity/hy-
drophobicity ratio could be an important factor to consider
with implications in the supramolecular properties and in
the transport capabilities of any given peptide. These impli-
cations would not only be limited to the level of delivery ef-
ficiency but also to the final mechanism of internalization.
With this paper we wanted to highlight the potential of dy-
namic bonds as powerful synthetic tools to modulate the
Figure 3  Cell transport experiments of the three oxime-modulated peptides CFP(T)2 and the control CFR8. (A) Quantification of the uptake of the 
peptides by fluorometry. HeLa cells were incubated for 30 min with the indicated fluorescein labeled peptides (4 μM) in HKR buffer. Cells were then 
washed and trypsinized and the cellular uptake was quantified by fluorometry. (B) Cell viability (MTT assay). Error bars indicate SD of three replicates. 
(C) Fluorescence microscopy images, with differential interference contrast (DIC) insets, of the three peptides and CFR8 in HeLa cells. Cells were thor-
oughly washed before imaging. Nuclei were stained blue with Hoechst. [Peptide] = 4 μM in all cases.
Figure 4  Lysosomal staining of cells incubated with the peptides. After three hours of incubation with the fluorescein-labelled peptides (green), cells 
were stained with LysoTracker Deep Red (red). Nuclei were counterstained with Hoechst (blue). Some co-localization between the lysosomal marker 
and the four peptides is observed with particular high intensity for the case of CFP(TGly)2 and CFR8 at 4 μM. For the high penetrating CFP(TAcet)2 and 
CFP(TGua)2 it was necessary to dilute the concentration to 2 μM to avoid signal saturation and observe the colocalization.Georg Thieme Verlag  Stuttgart · New York — Synlett 2017, 28, A–E
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cused on the synthetic advantage of the oxime bonds. How-
ever, in the future, we hope that also the dynamic character
and the response to external stimuli of dynamic covalent
chemistry will allow us to understand cell penetration and
to develop novel and superior intracellular delivery vehicles.
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